Hydrosalpinx: Why It Matters Before Another IVF Transfer
Key Takeaways
Hydrosalpinx is a fallopian tube that has become blocked and filled with fluid. When that fluid can reach the uterine cavity, it may reduce embryo implantation in IVF. Before transfer, a specialist may discuss salpingectomy or proximal tubal occlusion, depending on the anatomy and the risk to the ovarian blood supply.
Key evidence: ASRM — Tubal surgery in the ART era (2021) WHO — Tubal factor disease guideline (2025) Hydrosalpinx and pregnancy loss — systematic review (PMID 30665848)
Salpingitis: Symptoms, Causes and Impact on Fertility — Dr. Senai Aksoy
This video is in French; English and Arabic dubbing and subtitles are available in the YouTube player settings. It complements the article but does not replace an individual medical assessment.
On this page
- Hydrosalpinx before the next transfer
- Why it matters for fertility
- Common causes
- Symptoms and clinical presentation
- How it is diagnosed
- Why it can lower IVF success
- Treatment options before transfer
- Practical checklist before another transfer
- Related reading
- FAQ
- Sources
Hydrosalpinx before the next transfer
Hydrosalpinx means that a fallopian tube has become blocked and filled with fluid. It often follows pelvic infection or inflammation, endometriosis, or previous surgery. The tube becomes distended and no longer functions normally.
Some people notice pelvic pain, pressure, or unusual discharge. Many discover it only during an infertility evaluation, for example on a hysterosalpingogram (HSG) or an ultrasound. That finding can change the timing of the next IVF cycle.
This guide focuses on the practical transfer-timing question: why a specialist may pause the cycle, which options can be discussed, and how this decision relates to our broader overview of hydrosalpinx treatment and infertility.
Dr. Aksoy’s Approach
“When an ultrasound or HSG shows a hydrosalpinx that communicates with the uterine cavity, I start with one practical question: can the fluid reach the endometrium?
“If salpingectomy can be performed safely without compromising the ovarian blood supply, it is often the preferred surgical option. When dense adhesions make removal hazardous, proximal tubal occlusion may be a reasonable alternative. The choice is anatomical and individual; it is not automatic for every patient.
“The aim is not to make a promise about one future cycle. It is to address a finding that may interfere with the uterine environment before an embryo is transferred.”
Why it matters for fertility
Hydrosalpinx can affect fertility through more than one mechanism:
- Mechanical blockage: The affected tube cannot provide a normal route for the egg and sperm to meet.
- Inflammatory fluid: The fluid contains inflammatory mediators and cellular products that may affect early embryo development.
- Reflux into the uterine cavity: When the hydrosalpinx communicates with the uterus, fluid may flow back into the cavity and interfere with endometrial receptivity during implantation.
The evidence points in the same direction, but the studies answer different questions. The Strandell randomized trial reported better delivery outcomes after salpingectomy than no intervention in women with hydrosalpinx before IVF.
In a separate systematic review and meta-analysis of 14 observational studies, hydrosalpinx was associated with a higher risk of pregnancy loss (RR 1.74, 95% CI 1.43–2.12). This is an association, not proof that hydrosalpinx caused every individual loss.
Common causes
The most common underlying cause is previous pelvic inflammatory disease, often linked to Chlamydia trachomatis or Neisseria gonorrhoeae. Other causes include:
- Endometriosis with pelvic adhesions
- Previous pelvic or lower abdominal surgery
- Adhesions after pelvic infection or surgery
- Less commonly, genital tuberculosis or another pelvic infection
The cause matters for the wider fertility assessment. For transfer planning, the more immediate question is whether a distended, fluid-filled tube communicates with the uterine cavity.
Symptoms and clinical presentation
Hydrosalpinx may cause physical symptoms, but it can also be silent:
- Physical symptoms (when present): Persistent or intermittent pelvic pain or pressure, pain during intercourse, and unusual or ongoing vaginal discharge.
- Fertility-care presentation: Some patients have no pelvic pain and are assessed because of secondary infertility or repeated implantation failure.
Symptoms alone cannot confirm or exclude hydrosalpinx. The diagnosis and next step depend on appropriate imaging and the wider clinical picture.
How it is diagnosed
Evaluation usually combines targeted imaging with the clinical history:
- Transvaginal ultrasound: May show a tubular, fluid-filled structure beside the ovary.
- Hysterosalpingography (HSG): Can show tubal blockage and the pattern of contrast spill.
- Diagnostic laparoscopy: Offers a direct view of the tubes and pelvic adhesions when non-invasive imaging is unclear or surgery is already being considered.
Bringing the original HSG DICOM files or clear imaging reports to a consultation can help avoid unnecessary repeat testing.
Why it can lower IVF success
The ASRM committee opinion on tubal surgery describes several possible mechanisms: mechanical flushing from the uterine cavity, reduced endometrial receptivity, and direct effects of the fluid on the embryo. These mechanisms are most relevant when the hydrosalpinx communicates with the uterus.
Assessing the hydrosalpinx before transfer can help the team plan the sequence of treatment, retrieval, and embryo transfer. It may also avoid waiting until after repeated failed attempts to revisit the same finding. For more detail on the options, see our companion article on hydrosalpinx treatment and infertility.
Treatment options before transfer
When IVF is planned and a hydrosalpinx communicates with the uterine cavity, current guidance supports discussing surgical management before transfer. The ASRM committee opinion and the WHO 2025 guideline both emphasize that the choice depends on anatomy and feasibility; WHO rates the certainty of the evidence as very low.
- Laparoscopic salpingectomy: Removal of the affected tube. It is often the preferred option when it can be performed without compromising the ovarian blood supply.
- Proximal tubal occlusion: Blocking the tube close to the uterus with a clip or cautery. It may be considered when dense adhesions make removal more hazardous; the Cochrane review found that direct comparisons with salpingectomy remain uncertain.
- Salpingostomy: Creating a new opening in the tube. This may be considered for selected patients seeking natural conception, but it is not a routine substitute for treating a communicating hydrosalpinx before IVF.
- Antibiotics: Useful for an active infection when prescribed by a clinician, but they do not reverse a structurally damaged, fluid-filled tube.
If immune-based testing or treatment is being discussed after failed IVF, first make sure the tubal finding has been assessed properly. That is a separate question from whether an immune add-on helps; imaging, medical history, and the strength of the evidence should guide the sequence. See our overview on immune treatments after failed IVF.
Practical checklist before another transfer
- Ask your fertility specialist to review the HSG or ultrasound images, not only the written report.
- Clarify whether the hydrosalpinx is on one side or both, and whether it communicates with the uterine cavity.
- Ask why salpingectomy or proximal occlusion is being considered before embryo transfer.
- Discuss the timing of ovarian stimulation, egg retrieval, and surgery if pelvic access may be difficult.
- Keep the surgical and IVF timelines together so that the next step is clear, especially when care involves travel.
Related reading
- Hydrosalpinx treatment and infertility
- Pelvic inflammatory disease: causes and fertility risks
- Immune treatments after failed IVF
FAQ
How serious is hydrosalpinx for fertility?
It can matter, particularly when the fluid-filled tube communicates with the uterus. It may reduce natural fertility and IVF implantation, but it does not predict one person’s outcome on its own. The next step depends on the imaging and the wider fertility assessment.
Can hydrosalpinx be treated without surgery?
Medication cannot remove a structurally damaged hydrosalpinx. Antibiotics may treat an active infection, but they do not reopen a sealed tube or stop sterile fluid from collecting.
Does every patient with hydrosalpinx need tubal removal?
No. Salpingectomy is often discussed when it can be performed safely, while proximal tubal occlusion may be considered when adhesions make removal risky for the ovarian blood supply. WHO describes both options as conditional choices supported by very low-certainty evidence.
Which bacteria are most frequently responsible?
Chlamydia trachomatis and Neisseria gonorrhoeae are common bacterial causes of pelvic inflammatory disease, which can leave tubal scarring and hydrosalpinx. The cause still needs to be assessed in the individual patient.
Sources
- American Society for Reproductive Medicine. Role of tubal surgery in the era of assisted reproductive technology: a committee opinion. Fertil Steril 2021;115(5):1143–1150.
- Strandell A, Lindhard A, Waldenström U, et al. Hydrosalpinx and IVF outcome: a prospective, randomised multicentre trial in Scandinavia on salpingectomy prior to IVF. Hum Reprod 1999;14(11):2762–2769.
- Harb H, Al-Rshoud F, Karunakaran B, Gallos ID, Coomarasamy A. Hydrosalpinx and pregnancy loss: a systematic review and meta-analysis. Reprod Biomed Online 2019;38(3):427–441. doi:10.1016/j.rbmo.2018.12.020.
- Johnson N, van Voorst S, Sowter MC, et al. Surgical treatment for hydrosalpinx prior to in-vitro fertilisation. Cochrane Database Syst Rev 2010;(1):CD002125.
- World Health Organization. Guideline for the prevention, diagnosis and treatment of infertility — tubal factor disease. Geneva: WHO, 2025.
For educational purposes only. Last editorial review: 9 August 2026.
Add as a Preferred Source on Google
You can add draksoyivf.com as one of your preferred health information sources on Google.
The content has been created by Dr. Senai Aksoy and medically approved.